tiprankstipranks
Trending News
More News >
ALT5 Sigma Corporation (ALTS)
NASDAQ:ALTS

ALT5 Sigma Corporation (ALTS) AI Stock Analysis

Compare
202 Followers

Top Page

AL

ALT5 Sigma Corporation

(NASDAQ:ALTS)

Rating:46Neutral
Price Target:
ALT5 Sigma Corporation's stock score of 46 reflects its financial challenges, including profitability issues and a leveraged balance sheet, despite recent revenue growth and positive cash flow generation. Technical analysis indicates mixed short-term momentum with some long-term strength, while the valuation is unattractive due to a negative P/E ratio.

ALT5 Sigma Corporation (ALTS) vs. SPDR S&P 500 ETF (SPY)

ALT5 Sigma Corporation Business Overview & Revenue Model

Company DescriptionALT5 Sigma Corporation operates a next generation blockchain platform. It engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. The company's products include ALT 5 Prime, an electronic over-the-counter trading platform to buy and sell digital assets; and ALT 5 Pay that enables payment processors to accept digital assets as payments, as well as make payment in digital assets. It is also involved in the developing of solutions for opioid crisis. The company was formerly known as JanOne Inc. and changed its name to ALT5 Sigma Corporation in July 2024. ALT5 Sigma Corporation was founded in 1976 and is based in Las Vegas, Nevada.
How the Company Makes MoneyALT5 Sigma Corporation generates revenue primarily through its digital asset trading platforms and custody services. The company charges transaction fees for trades executed on its platforms, which serve as a significant revenue stream. Additionally, ALT5 Sigma earns money by offering secure custody solutions that provide institutions and investors a safe way to store their digital assets, with fees based on the volume of assets under management. The company may also engage in strategic partnerships with financial institutions to expand its service offerings and market reach, contributing to its overall earnings.

ALT5 Sigma Corporation Financial Statement Overview

Summary
ALT5 Sigma Corporation's financial performance shows significant challenges with recent revenue growth offset by profitability issues. The balance sheet is leveraged but shows improvement in equity, while cash flow generation is positive but inconsistent.
Income Statement
40
Negative
ALT5 Sigma Corporation has shown a volatile revenue trend, with zero revenue in recent years until 2024. The gross profit margin is positive at 50.2% for 2024, but the company suffers from negative net profit margins due to substantial EBIT and EBITDA losses. Despite revenue growth in 2024, the consistent net losses highlight profitability challenges.
Balance Sheet
45
Neutral
The company's balance sheet reflects a moderate debt-to-equity ratio of 0.63, indicating a leveraged capital structure. Positive stockholders' equity in 2024 marks an improvement from prior deficits. However, the equity ratio of 25.3% suggests a reliance on liabilities, posing potential financial stability risks.
Cash Flow
50
Neutral
ALT5 Sigma Corporation has managed positive operating cash flow in 2024, with a free cash flow that matches operating cash flow due to no capital expenditures reported. The operating cash flow to net income ratio is positive, indicating efficient cash generation despite net losses. However, historical fluctuations in cash flow raise concerns about sustainability.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
12.53M0.000.0040.02M33.87M
Gross Profit
6.29M0.000.008.87M8.83M
EBIT
-7.56M-19.85M-3.15M-3.22M-9.00M
EBITDA
-4.97M-3.29M-3.15M1.90M-4.30M
Net Income Common Stockholders
-6.25M-7.81M10.99M-16.89M-8.50M
Balance SheetCash, Cash Equivalents and Short-Term Investments
7.18M5.00K61.00K705.00K379.00K
Total Assets
82.44M18.49M46.76M15.16M24.35M
Total Debt
13.07M707.00K7.67M6.64M6.63M
Net Debt
5.89M702.00K7.61M5.94M6.25M
Total Liabilities
57.63M21.80M44.45M23.84M21.98M
Stockholders Equity
20.89M-3.31M2.31M-8.68M2.37M
Cash FlowFree Cash Flow
1.78M1.46M-3.06M-7.02M-1.45M
Operating Cash Flow
1.78M1.46M-3.06M-5.29M-617.00K
Investing Cash Flow
5.85M-155.00K-1.51M-1.72M-834.00K
Financing Cash Flow
6.09M-1.44M3.98M7.37M1.40M

ALT5 Sigma Corporation Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price8.25
Price Trends
50DMA
6.93
Positive
100DMA
6.15
Positive
200DMA
4.57
Positive
Market Momentum
MACD
0.73
Positive
RSI
47.54
Neutral
STOCH
30.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ALTS, the sentiment is Neutral. The current price of 8.25 is below the 20-day moving average (MA) of 9.12, above the 50-day MA of 6.93, and above the 200-day MA of 4.57, indicating a neutral trend. The MACD of 0.73 indicates Positive momentum. The RSI at 47.54 is Neutral, neither overbought nor oversold. The STOCH value of 30.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ALTS.

ALT5 Sigma Corporation Risk Analysis

ALT5 Sigma Corporation disclosed 19 risk factors in its most recent earnings report. ALT5 Sigma Corporation reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ALT5 Sigma Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$4.49B12.225.40%3.71%4.17%-11.97%
46
Neutral
$165.82M-41.79%87.49%
$92.26M
54
Neutral
$88.10M-189.13%89.27%26.30%
37
Underperform
$65.55M-19.87%
$64.81M0.59
52
Neutral
$54.70M-170.91%-70.08%-330.51%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ALTS
ALT5 Sigma Corporation
8.25
5.82
239.51%
TROO
TROOPS
0.90
-0.80
-47.06%
PHUN
Phunware
3.18
-1.91
-37.52%
DUOT
Duos Technologies Group
7.61
5.06
198.43%
NUKK
Nukkleus
10.64
5.48
106.20%
SURG
SurgePays
2.69
-0.74
-21.57%

ALT5 Sigma Corporation Corporate Events

Executive/Board ChangesM&A TransactionsShareholder MeetingsBusiness Operations and Strategy
ALT5 Sigma Announces Strategic Spin-Off and Growth Plans
Positive
Dec 19, 2024

At its 2024 Annual General Meeting, ALT5 Sigma Corporation’s shareholders approved all proposed resolutions, including the re-election of key board members and the approval of the 2024 Equity Incentive Plan. The company reported record transaction volumes for its fintech platforms, reflecting strong customer trust and growth. Strategic initiatives include the planned spin-off of healthcare assets into Alyea Therapeutics Corporation, which is set to acquire Soin Bioscience LLC to enhance its pain management pharmaceutical pipeline. This separation will allow ALT5 to focus on its fintech operations while Alyea concentrates on healthcare innovations.

More about ALT5 Sigma Corporation

ALT5 Sigma Corporation is a Nasdaq-listed fintech firm specializing in blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safekeeping of digital assets. It operates the ALT5 Pay and ALT5 Prime platforms, which facilitate cryptocurrency payments and digital asset trading. The company is also engaged in developing non-addictive pain management solutions through its subsidiary, Alyea Therapeutics Corporation.

YTD Price Performance: 528.57%

Average Trading Volume: 170,649

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $49.52M

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.